Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Observational Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

NCT03433001 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03433001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Observational Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
April 2, 2018
Completion date
June 11, 2021
Enrollment
295 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed and/or refractory multiple myeloma